EP3534913A4 - Composition and method for treating otitis - Google Patents
Composition and method for treating otitis Download PDFInfo
- Publication number
- EP3534913A4 EP3534913A4 EP17868280.3A EP17868280A EP3534913A4 EP 3534913 A4 EP3534913 A4 EP 3534913A4 EP 17868280 A EP17868280 A EP 17868280A EP 3534913 A4 EP3534913 A4 EP 3534913A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- composition
- treating otitis
- otitis
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/04—Amoebicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/18—Iodine; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/341,930 US20170071979A1 (en) | 2011-05-11 | 2016-11-02 | Composition and method for treating otitis |
PCT/US2017/059513 WO2018085384A1 (en) | 2016-11-02 | 2017-11-01 | Composition and method for treating otitis |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3534913A1 EP3534913A1 (en) | 2019-09-11 |
EP3534913A4 true EP3534913A4 (en) | 2020-07-15 |
Family
ID=60860035
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP17868280.3A Withdrawn EP3534913A4 (en) | 2016-11-02 | 2017-11-01 | Composition and method for treating otitis |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP3534913A4 (en) |
JP (3) | JP6255134B1 (en) |
KR (3) | KR20190100442A (en) |
CN (1) | CN108472313A (en) |
WO (1) | WO2018085384A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2021161105A (en) * | 2020-03-31 | 2021-10-11 | タイ ミン ファーマシューティカルズ ジェイエスシー | Composition for preventing or treating chronic or acute virus infection and/or sepsis in humans or animals |
WO2021198940A1 (en) * | 2020-03-31 | 2021-10-07 | タイ ミン ファーマシューティカルズ ジェイエスシー | Composition for preventing or treating chronic or acute virus infection and/or sepsis in humans or animals |
FR3122572A1 (en) * | 2021-05-07 | 2022-11-11 | Nadine GRISLAIN | Bioadhesive pharmaceutical composition comprising PVPI |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060280809A1 (en) * | 2005-06-14 | 2006-12-14 | Leshchiner Adele K | Anti-infective iodine based compositions for otic and nasal use |
WO2013040347A1 (en) * | 2011-09-16 | 2013-03-21 | Foresight Biotherapeutics, Inc. | Stable povidone-iodine compositions |
WO2016118424A1 (en) * | 2015-01-20 | 2016-07-28 | Veloce Biopharma Llc | Novel iodophor composition and methods of use |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4241051A (en) * | 1977-11-04 | 1980-12-23 | Christie Robert B | Calcitonin |
CN101137359B (en) * | 2005-03-10 | 2011-01-12 | 3M创新有限公司 | Methods of treating ear infections |
DE202005004183U1 (en) * | 2005-03-14 | 2005-05-25 | G. Pohl-Boskamp Gmbh & Co. Kg | Formulation for analgesic ear drops contains polyhydric alcohol, especially butan-1,3-diol or glycerol, dimethyl sulfoxide and optionally acid or buffer system and dexpanthenol |
CN101002775A (en) * | 2006-01-18 | 2007-07-25 | 广州白云山制药股份有限公司广州白云山制药总厂 | Anti-inflective preparation |
GB0709513D0 (en) * | 2007-05-17 | 2007-06-27 | Helperby Therapeutics Ltd | Topical formulations |
US20090263345A1 (en) * | 2008-01-28 | 2009-10-22 | Foresight Biotherapeutics, Inc. | Otic compositions for the treatment of infections of the internal and external ear in mammals |
US20100016450A1 (en) * | 2008-07-21 | 2010-01-21 | Otonomy, Inc. | Controlled release delivery devices for the treatment of otic disorders |
EP2512230A4 (en) * | 2009-12-15 | 2013-05-22 | Foresight Biotherapeutics Inc | Non-irritating ophthalmic povidone-iodine compositions |
CA2786525A1 (en) * | 2010-01-07 | 2011-07-14 | Regents Of The University Of Minnesota | Methods and compositions for applying moxifloxacin to the ear |
PL2366408T3 (en) * | 2010-03-01 | 2013-01-31 | Salvat Lab Sa | Aqueous clear solutions of fluocinolone acetonide for treatment of otic inflammation |
ES2665986T3 (en) * | 2011-05-11 | 2018-04-30 | Veloce Biopharma Llc | Antifungal compositions for nail treatment |
US20140271529A1 (en) * | 2013-03-14 | 2014-09-18 | Alc Therapeutics, Llc | Antifungal compositions for the treatment of secondary skin and nail infections |
US9539223B2 (en) * | 2013-05-01 | 2017-01-10 | Neoculi Pty Ltd | Methods for treating bacterial infections |
-
2017
- 2017-07-21 JP JP2017141605A patent/JP6255134B1/en not_active Expired - Fee Related
- 2017-11-01 KR KR1020197024236A patent/KR20190100442A/en active Application Filing
- 2017-11-01 KR KR1020187013133A patent/KR20180059554A/en not_active Application Discontinuation
- 2017-11-01 EP EP17868280.3A patent/EP3534913A4/en not_active Withdrawn
- 2017-11-01 KR KR1020187012808A patent/KR20180061359A/en active Application Filing
- 2017-11-01 WO PCT/US2017/059513 patent/WO2018085384A1/en unknown
- 2017-11-01 CN CN201780002919.6A patent/CN108472313A/en active Pending
- 2017-11-14 JP JP2017218785A patent/JP6271804B1/en not_active Expired - Fee Related
- 2017-12-26 JP JP2017249207A patent/JP2018070655A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060280809A1 (en) * | 2005-06-14 | 2006-12-14 | Leshchiner Adele K | Anti-infective iodine based compositions for otic and nasal use |
WO2013040347A1 (en) * | 2011-09-16 | 2013-03-21 | Foresight Biotherapeutics, Inc. | Stable povidone-iodine compositions |
WO2016118424A1 (en) * | 2015-01-20 | 2016-07-28 | Veloce Biopharma Llc | Novel iodophor composition and methods of use |
Non-Patent Citations (3)
Title |
---|
LINDA K WONG ET AL: "Volume 46 | Issue 2 Clinical Considerations of Dimethyl Sulfoxide Recommended Citation Clinical Considerations of Dimethyl Sulfoxide", 1 January 1984 (1984-01-01), XP055700607, Retrieved from the Internet <URL:https://lib.dr.iastate.edu/cgi/viewcontent.cgi?referer=https://www.google.com/&httpsredir=1&article=3126&context=iowastate_veterinarian> [retrieved on 20200603] * |
ROSYCHUK R A W: "MANAGEMENT OF OTITIS EXTERNA", VETERINARY CLINICS OF NORTH AMERICA: SMALL ANIMAL PRACTICE, SAUNDERS, PHILADELPHIA, US, vol. 24, no. 5, 1 September 1994 (1994-09-01), pages 921 - 953, XP000670927, ISSN: 0195-5616 * |
See also references of WO2018085384A1 * |
Also Published As
Publication number | Publication date |
---|---|
JP2018070583A (en) | 2018-05-10 |
WO2018085384A1 (en) | 2018-05-11 |
EP3534913A1 (en) | 2019-09-11 |
JP6271804B1 (en) | 2018-01-31 |
JP2018070655A (en) | 2018-05-10 |
KR20190100442A (en) | 2019-08-28 |
JP2018070620A (en) | 2018-05-10 |
KR20180059554A (en) | 2018-06-04 |
CN108472313A (en) | 2018-08-31 |
KR20180061359A (en) | 2018-06-07 |
JP6255134B1 (en) | 2017-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3555077A4 (en) | Compositions and methods for treating cancer | |
EP3247359A4 (en) | Composition and method for treating seizure disorders | |
EP3490582A4 (en) | Methods and compositions for treating myelofibrosis | |
EP3532464A4 (en) | Compositions and methods for treating ezh2-mediated cancer | |
EP3681525A4 (en) | Composition and method for treating autism | |
EP3193862A4 (en) | Cannabinoid composition and method for treating pain | |
EP3277270A4 (en) | Compositions and methods for treating anemia | |
EP3704227A4 (en) | Composition and method | |
EP3462883A4 (en) | Compositions and methods for treating cancer | |
EP3261644A4 (en) | Compositions and methods for treating retinal degradation | |
EP3359663A4 (en) | Composition and method for treating complement-mediated disease | |
EP3458158A4 (en) | Compositions and methods for treating eczema | |
EP3402575A4 (en) | Methods and compositions for treating damaged hair | |
EP3528798A4 (en) | Compositions and methods for treating cancer | |
EP3471746A4 (en) | Method and composition for treating seizure disorders | |
EP3405172A4 (en) | Methods and compositions for treating aged skin | |
EP3458079A4 (en) | Compositions and methods for treating acne | |
EP3405191A4 (en) | Methods and compositions for treating hyperhidrosis | |
EP3541421A4 (en) | Compositions and methods for treating cancer | |
EP3468546A4 (en) | Compositions and methods for treating cancer | |
EP3352729A4 (en) | Method and compositions for treating skin | |
EP3429613A4 (en) | Compositions and methods for treating cancers | |
EP3262065A4 (en) | Methods and compositions for treating dystroglycanopathy disorders | |
HK1243635A1 (en) | Composition and method for treating skin conditions | |
EP3411367A4 (en) | Compositions and methods for treating infections |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20190531 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20200616 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 31/04 20060101ALI20200609BHEP Ipc: A61P 27/16 20060101ALI20200609BHEP Ipc: A61P 31/10 20060101ALI20200609BHEP Ipc: A61K 47/58 20170101ALI20200609BHEP Ipc: A61P 33/04 20060101ALI20200609BHEP Ipc: A61K 47/38 20060101ALI20200609BHEP Ipc: A61K 9/06 20060101ALI20200609BHEP Ipc: A61K 9/00 20060101ALI20200609BHEP Ipc: A61K 47/06 20060101ALI20200609BHEP Ipc: A61P 31/12 20060101ALI20200609BHEP Ipc: A61P 31/02 20060101ALI20200609BHEP Ipc: A61K 47/32 20060101ALI20200609BHEP Ipc: A61K 33/18 20060101AFI20200609BHEP Ipc: A61K 47/10 20170101ALI20200609BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20220601 |